U.S. preventive care experts now recommend starting routine breast cancer screening at age 40 for women at average risk. Here’s what changed, who it affects, and how to decide what’s right for you.
Skin cancer remains the most common cancer in the United States. Here’s what current CDC, USPSTF, and FDA guidance says about sunscreen, UV exposure, and who should take extra precautions.
Cancer screening can lower the risk of dying from certain cancers—but only when it’s used at the right time and for the right people. Here’s what current U.S. recommendations say about breast, colorectal, lung, cervical, and prostate cancer screening, and how to decide what’s appropriate for you.
Blood in the urine can be alarming. Here’s what it may signal about bladder health, when to seek care, and what U.S. guidelines say about evaluation and cancer risk.
Cancer remains a leading cause of death in the United States, but prevention, screening, and treatment continue to improve. Here’s what current public health evidence shows—and what it means for individuals and families.
As spring and summer approach, public health agencies are reinforcing practical steps to prevent skin cancer. Here’s what the evidence shows about sunscreen, tanning, and early detection—and what it means for you and your family.
Colorectal cancer rates are rising in adults under 50 in the United States. Researchers are still working to understand why. Here’s what we know, what remains uncertain, and what it means for families.
Federal health agencies continue to monitor the safety of breast implants, including rare cancer risks and other complications. Here’s what the evidence shows, who may be affected, and what to discuss with your surgeon.
Ablation is a minimally invasive medical procedure used to treat abnormal heart rhythms, heavy menstrual bleeding, certain cancers, and chronic pain. Here’s what it involves, who may benefit, and what to consider before treatment.
This article offers a clear, reassuring guide to early cancer warning signs—such as unexplained weight loss, persistent fatigue, new or changing lumps, skin changes, unusual bleeding, a lingering cough or hoarseness, difficulty swallowing, and changes in bowel or bladder habits. It explains why persistence and patterns matter, how to track symptoms, and when to contact a healthcare professional, while emphasizing that many of these signs have noncancerous causes. Readers will learn how early detection improves outcomes, how to discuss age- and risk-appropriate screening, and what questions to ask at appointments. With practical tips and pointers to trusted resources, it empowers patients and caregivers to act promptly and confidently without undue alarm.
This article explains how cancer care in 2025 is becoming more personalized, with biomarker testing guiding targeted drugs, next‑generation immunotherapies (including CAR-T and bispecifics), antibody-drug conjugates, and radiopharmaceuticals, alongside smarter use of precision radiation. It outlines how liquid biopsies and AI-enhanced imaging help match treatments and monitor response earlier, including minimal residual disease, to adjust care sooner. You’ll learn the potential benefits and risks, common side effects to discuss, and practical steps for accessing clinical trials, managing costs, and coordinating supportive care. Designed for patients and caregivers, it offers clear questions to bring to appointments and points to trustworthy resources so you can make informed, confident decisions with your oncology team.
This article demystifies cancer staging so you can better understand what diagnosis numbers really mean and how they guide care. In clear terms, it explains stage 0–IV, the TNM system (tumor size, lymph nodes, metastasis), and terms like localized, regional, and distant. You’ll learn how stage differs from grade and biomarkers, why staging varies by cancer type, and how it shapes treatment choices, prognosis discussions, and eligibility for clinical trials. It also clarifies common misconceptions—such as why a stage label usually doesn’t change even if tumors shrink—and offers practical questions to ask your care team. Supportive and evidence-based, it helps patients and caregivers feel informed, prepared, and empowered in decision-making.
Research shows that everyday choices can meaningfully lower the risk of several common cancers. The strongest evidence supports not smoking (and avoiding secondhand smoke), limiting alcohol, staying physically active, maintaining a healthy weight, eating a plant-forward, high‑fiber diet with fewer processed and red meats, practicing sun safety, getting recommended vaccines (HPV and hepatitis B), minimizing exposure to carcinogens, and keeping up with cancer screening. Benefits add up at any age, and small, realistic changes can help. Patients and caregivers can work with clinicians to tailor goals and use trustworthy guidelines and community resources for support.
Genetic testing for cancer can clarify inherited risk, guide prevention, and inform treatment, but it isn’t necessary for everyone. People who may benefit most include those with a strong family history of certain cancers, cancer at a young age, multiple related cancers in one person, rare cancer types, specific ancestries with higher-risk variants, distinctive tumor features, or a known familial mutation. Testing can lead to tailored screening and risk-reducing options, eligibility for targeted therapies, and valuable information for relatives. Because results can have medical and emotional implications—and sometimes don’t change care—speaking with a genetic counselor or knowledgeable clinician helps you decide whether testing is right for you and how to act on the findings.
The EPA’s decision to ban perchloroethylene (PERC) ushers in a new era of chemical safety. Discover why this dry cleaning solvent faced scrutiny, what industries can expect next, and how this ban benefits public health and the environment.
The EPA’s ban on trichloroethylene (TCE), a known carcinogen, marks a pivotal shift in U.S. chemical regulation. Learn what led to the ban, how it impacts industries, and what it means for public health.
Early Detection: Key to Effective Cancer Treatment and Improved Survival
Navigating Cancer Treatment: Key Strategies to Manage Side Effects Effectively
Recognizing Early Cancer Symptoms: Key Warning Signs to Watch For
Unlocking Chemotherapy: Your Comprehensive Guide to Cancer Treatment
Exploring How Your DNA Shapes Cancer Risk: Unlocking the Genetic Code
Explore the Various Types of Cancer: A Comprehensive Guide for Understanding
End of content
End of content
